Book Reviews
In: Publius: the journal of federalism, Band 30, Heft 3, S. 105-107
ISSN: 1747-7107
12 Ergebnisse
Sortierung:
In: Publius: the journal of federalism, Band 30, Heft 3, S. 105-107
ISSN: 1747-7107
In: Publius: the journal of federalism, Band 29, Heft 4, S. 120-122
ISSN: 1747-7107
In: Journal of Comparative Legislation and International Law, Band 20, S. 230-241
In: Australian quarterly: AQ, Band 35, Heft 1, S. 118
ISSN: 1837-1892
In: Australian quarterly: AQ, Band 33, Heft 3, S. 115
ISSN: 1837-1892
In: Publius: the journal of federalism, Band 26, Heft 3, S. 109-126
ISSN: 1747-7107
In: Australian quarterly: AQ, Band 36, Heft 4, S. 113
ISSN: 1837-1892
In: Cattrell , A , Harris , E C , Palmer , K T , Kim , M , Aylward , M & Coggon , D 2011 , ' Regional trends in awards of incapacity benefit by cause ' , Occupational Medicine , vol. 61 , no. 3 , pp. 148 - 151 . https://doi.org/10.1093/occmed/kqr008
Background Since the early 1990s, rates of incapacity benefit ( IB) in Britain for musculoskeletal complaints have declined, and they have been overtaken by mental and behavioural disorders as the main reason for award of IB. Aims To explore reasons for this change. Methods Using data supplied by the Department for Work and Pensions, we analysed trends in the ratio of new IB awards for mental and behavioural disorders to those for musculoskeletal disorders during 1997-2007 by Government region. Results In Great Britain overall, the above ratio more than doubled over the study period, as a consequence of falling numbers of new awards for musculoskeletal disorders. The extent to which the ratio increased was smallest in London (50%) and South-East England (56%), and was progressively larger in more northerly regions (> 150% in North-East England and Scotland). Conclusions The differences in trends between regions seem too large to be explained by differential changes in working conditions, patterns of employment or the rigour with which claims were assessed. An alternative explanation could be that the main driver for the trends has been culturally determined changes in health beliefs and expectations, and that these cultural changes began in London and the South-East, only later spreading to other parts of Britain.
BASE
Patients with multimorbidity have complex health needs but, due to the current traditional disease-oriented approach, they face a highly fragmented form of care that leads to inefficient, ineffective, and possibly harmful clinical interventions. There is limited evidence on available integrated and multidimensional care pathways for multimorbid patients. An expert consensus meeting was held to develop a framework for care of multimorbid patients that can be applied across Europe, within a project funded by the European Union; the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). The experts included a diverse group representing care providers and patients, and included general practitioners, family medicine physicians, neurologists, geriatricians, internists, cardiologists, endocrinologists, diabetologists, epidemiologists, psychologists, and representatives from patient organizations. Sixteen components across five domains were identified (Delivery of Care; Decision Support; Self Management Support; Information Systems and Technology; and Social and Community Resources). The description and aim of each component are described in these guidelines, along with a summary of key characteristics and relevance to multimorbid patients. Due to the lack of evidence-based recommendations specific to multimorbid patients, this care model needs to be assessed and validated in different European settings to examine specifically how multimorbid patients will benefit from this care model, and whether certain components have more importance than others. ; final draft ; peerReviewed
BASE
In: Proceedings of the Estonian Academy of Sciences, Band 63, Heft 2S, S. 279
ISSN: 1736-7530
In: Reproductive sciences: RS : the official journal of the Society for Reproductive Investigation, Band 28, Heft 5, S. 1489-1497
ISSN: 1933-7205
Background Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, and concerns that artemisinin resistance might be engendered. Methods and Findings With evidence of a deteriorating situation, a group of police, criminal analysts, chemists, palynologists, and health workers collaborated to determine the source of these counterfeits under the auspices of the International Criminal Police Organization (INTERPOL) and the Western Pacific World Health Organization Regional Office. A total of 391 samples of genuine and counterfeit artesunate collected in Vietnam (75), Cambodia (48), Lao PDR (115), Myanmar (Burma) (137) and the Thai/Myanmar border (16), were available for analysis. Sixteen different fake hologram types were identified. High-performance liquid chromatography and/or mass spectrometry confirmed that all specimens thought to be counterfeit (195/391, 49.9%) on the basis of packaging contained no or small quantities of artesunate (up to 12 mg per tablet as opposed to ~ 50 mg per genuine tablet). Chemical analysis demonstrated a wide diversity of wrong active ingredients, including banned pharmaceuticals, such as metamizole, and safrole, a carcinogen, and raw material for manufacture of methylenedioxymethamphetamine ('ecstasy'). Evidence from chemical, mineralogical, biological, and packaging analysis suggested that at least some of the counterfeits were manufactured in southeast People's Republic of China. This evidence prompted the Chinese Government to act quickly against the criminal traders with arrests and seizures. Conclusions An international multi-disciplinary group obtained evidence that some of the counterfeit artesunate was manufactured in China, and this prompted a criminal investigation. International cross-disciplinary collaborations may be ...
BASE